No Data
No Data
Guardian Pharmacy Services Full Year 2024 Earnings: EPS Misses Expectations
Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $24
Raymond James Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $25
Analysts Offer Insights on Healthcare Companies: Clene (CLNN), Perspective Therapeutics (CATX) and Guardian Pharmacy Services, Inc. Class A (GRDN)
Q4 2024 Guardian Pharmacy Services Inc Earnings Call
Guardian Pharmacy Services Reports Strong Revenue Growth